97 related articles for article (PubMed ID: 24345882)
1. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
Reddick WE; Taghipour DJ; Glass JO; Ashford J; Xiong X; Wu S; Bonner M; Khan RB; Conklin HM
Pediatr Blood Cancer; 2014 Jun; 61(6):1074-9. PubMed ID: 24464947
[TBL] [Abstract][Full Text] [Related]
3. Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate.
Harris RD; Bernhardt MB; Zobeck MC; Taylor OA; Gramatges MM; Schafer ES; Lupo PJ; Rabin KR; Scheurer ME; Brown AL
Cancer; 2023 Apr; 129(8):1287-1294. PubMed ID: 36692972
[TBL] [Abstract][Full Text] [Related]
4. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
Gaietto A; Panetta JC; Pauley JL; Relling MV; Ribeiro R; Ehrhardt MJ; Pui CH; Inaba H; Swanson HD
Cancer Chemother Pharmacol; 2024 Jun; 93(6):617-625. PubMed ID: 38416167
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Trajectories of Neurocognitive Functioning in Childhood Acute Lymphoblastic Leukemia.
Partanen M; Phipps S; Russell K; Anghelescu DL; Wolf J; Conklin HM; Krull KR; Inaba H; Pui CH; Jacola LM
J Pediatr Psychol; 2021 Feb; 46(2):168-178. PubMed ID: 33011782
[TBL] [Abstract][Full Text] [Related]
6. Outcomes among pediatric patients with cancer who are treated on trial versus off trial: A matched cohort study.
Schapira MM; Stevens EM; Sharpe JE; Hochman L; Reiter JG; Calhoun SR; Shah SA; Bailey LC; Bagatell R; Silber JH; Tai E; Barakat LP
Cancer; 2020 Aug; 126(15):3471-3482. PubMed ID: 32453441
[TBL] [Abstract][Full Text] [Related]
7. Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Hardy KK; Kairalla JA; Gioia AR; Weisman HS; Gurung M; Noll RB; Hinds PS; Hibbitts E; Salzer WL; Burke MJ; Winick NJ; Embry L
Pediatr Blood Cancer; 2023 Jul; 70(7):e30350. PubMed ID: 37129114
[TBL] [Abstract][Full Text] [Related]
8. Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.
Rupakumar T; Sankar A; Vijayasekharan K; Varikkattu Rajendran P; Chellapan Sojamani G; Rajeswari B; Nair M; Anandarajan R; Dennis D; Thankamony P
Br J Haematol; 2024 May; ():. PubMed ID: 38797523
[TBL] [Abstract][Full Text] [Related]
9. Characterization of brain development with neuroimaging in a female mouse model of chemotherapy treatment of acute lymphoblastic leukemia.
Gandy K; Koscik TR; Alexander T; Steinberg JD; Krull KR; van der Plas E
Transl Pediatr; 2024 Mar; 13(3):408-416. PubMed ID: 38590373
[TBL] [Abstract][Full Text] [Related]
10. Unusual radiographic presentation of methotrexate-induced leukoencephalopathy involving the internal capsule.
Zolyan A; Crawford JR
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36428027
[No Abstract] [Full Text] [Related]
11. Methotrexate Scarcity Among Children's Oncology Group Institutions: Results of a Multinational Survey.
Menig S; Militano O; Ostrenga A; Bernhardt MB; Lee B; Unguru Y
Oncologist; 2023 Dec; ():. PubMed ID: 38069904
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.
Cheung YT; Krull KR
Neurosci Biobehav Rev; 2015 Jun; 53():108-20. PubMed ID: 25857254
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.
Hesko C; Liu W; Srivastava DK; Brinkman TM; Diller L; Gibson TM; Oeffinger KC; Leisenring WM; Howell R; Armstrong GT; Krull KR; Henderson TO
Cancer; 2023 Sep; 129(18):2904-2914. PubMed ID: 37199722
[TBL] [Abstract][Full Text] [Related]
15. Utilization and Cost of Outpatient Rehabilitation Services for Pediatric Patients Treated for Acute Lymphoblastic Leukemia Using a Commercial Claims Database.
Gilchrist L; Tanner L; Finch M; Watson D; Hoover A; Turcotte L; Messinger Y
Arch Phys Med Rehabil; 2023 Nov; 104(11):1857-1864. PubMed ID: 37150426
[TBL] [Abstract][Full Text] [Related]
16. Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia.
Heilmann J; Vieth S; Möricke A; Attarbaschi A; Barbaric D; Bodmer N; Colombini A; Dalla-Pozza L; Elitzur S; Izraeli S; Mann G; Niggli F; Silvestri D; Stary J; Rizzari C; Valsecchi MG; Zapotocka E; Zimmermann M; Cario G; Schrappe M; Conter V
Haematologica; 2023 Dec; 108(12):3278-3286. PubMed ID: 37021527
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.
Jonart LM; Ostergaard J; Brooks A; Fitzpatrick G; Chen L; Gordon PM
Br J Haematol; 2023 May; 201(3):459-469. PubMed ID: 36535585
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Neurocognitive Functioning and Fine Motor Skills in Pediatric Cancer Survivors and Healthy Children.
Chipeeva N; Deviaterikova A; Glebova E; Romanova E; Karelin A; Kasatkin V
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497461
[TBL] [Abstract][Full Text] [Related]
19. Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg Study.
Peters S; Frisch S; Stock A; Merta J; Bäumer C; Blase C; Schuermann E; Tippelt S; Bison B; Frühwald M; Rutkowski S; Fleischhack G; Timmermann B
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497345
[TBL] [Abstract][Full Text] [Related]
20. Cranial MRI in Childhood Acute Leukemia during Treatment and Follow-Up Including the Impact of Intrathecal MTX-A Single-Center Study and Review of the Literature.
Mergen M; Scheid S; Schubmehl H; Backens M; Reith W; Graf N
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
